BioVie Newsroom

BioVie Analyst Ratings

BenzingaJul 1 18:53

ThinkEquity Initiates Coverage On BioVie With Buy Rating, Announces Price Target of $3

BenzingaJul 1 18:53

BioVie Analyst Ratings

BenzingaDec 1, 2023 01:17

Oppenheimer Adjusts BioVie Price Target to $5 From $12, Maintains Outperform Rating

MT NewswiresNov 30, 2023 22:35

BioVie (BIVI) Gets a Buy From Oppenheimer

TipRanksNov 10, 2023 23:06

Analysts Conflicted on These Consumer Goods Names: Yum! Brands (YUM) and BioVie (BIVI)

TipRanksNov 3, 2023 01:30

Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Altria Group (MO), Keurig Dr Pepper (KDP) and BioVie (BIVI)

TipRanksOct 26, 2023 21:39

Cantor Fitzgerald Reiterates Overweight on BioVie, Maintains $11 Price Target

BenzingaAug 22, 2023 21:21

BioVie Analyst Ratings

BenzingaAug 22, 2023 21:21

Cantor Fitzgerald Reiterates Overweight on BioVie, Maintains $11 Price Target

BenzingaJul 18, 2023 20:41

BioVie Analyst Ratings

BenzingaJul 18, 2023 20:40

Analysts Offer Insights on Healthcare Companies: Durect (DRRX), Pfizer (PFE) and BioVie (BIVI)

TipRanksMay 18, 2023 00:30

Oppenheimer Sticks to Their Buy Rating for BioVie (BIVI)

TipRanksMay 17, 2023 20:25

Oppenheimer Reiterates Outperform on BioVie, Maintains $12 Price Target

BenzingaMay 17, 2023 20:06

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Seagen (SGEN) and BioVie (BIVI)

TipRanksMar 6, 2023 20:36

Analysts Offer Insights on Healthcare Companies: BioVie (BIVI) and Monopar Therapeutics Inc (MNPR)

TipRanksFeb 15, 2023 00:35

BioVie Analyst Ratings

Benzinga Analyst RatingsFeb 14, 2023 21:07